Equity Overview
Price & Market Data
Price: $11.65
Daily Change: +$0.10 / 0.86%
Range: $10.70 - $11.96
Market Cap: $740,786,176
Volume: 797,183
Performance Metrics
1 Week: 7.97%
1 Month: -6.28%
3 Months: -18.13%
6 Months: -27.37%
1 Year: -0.43%
YTD: 5.53%
Company Details
Employees: 332
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.